• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普萘洛尔的剂量依赖性生物利用度。

Dose-dependent bioavailability of propranolol.

作者信息

Kopitar Z, Vrhova B, Lenardic A, Cvelbar P, Zorz M, Francetić I

出版信息

Int J Clin Pharmacol Ther Toxicol. 1986 Jun;24(6):319-22.

PMID:3733282
Abstract

The pharmacokinetics of orally administered propranolol in doses of 10, 40, 80 and 160 mg was studied in eight healthy volunteers in a cross-over trial. The analytical method applied made possible a parallel determination of propranolol and of 4-OH propranolol. The dose-dependent kinetics of orally administered propranolol was demonstrated. In our study linear dependence could be established only within a dosage range of 40 mg to 160 mg. Both substances determined in plasma, propranolol as well as 4-OH propranolol, show a tendency toward non-linearity, particularly at the lower dosage range between 10 and 40 mg.

摘要

在一项交叉试验中,对8名健康志愿者研究了口服剂量为10、40、80和160毫克普萘洛尔的药代动力学。所应用的分析方法能够同时测定普萘洛尔和4-羟基普萘洛尔。结果表明口服普萘洛尔具有剂量依赖性动力学。在我们的研究中,仅在40毫克至160毫克的剂量范围内可以建立线性关系。血浆中测定的两种物质,即普萘洛尔和4-羟基普萘洛尔,都显示出非线性趋势,特别是在10至40毫克的较低剂量范围内。

相似文献

1
Dose-dependent bioavailability of propranolol.普萘洛尔的剂量依赖性生物利用度。
Int J Clin Pharmacol Ther Toxicol. 1986 Jun;24(6):319-22.
2
Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Heart Dis. 2003 May-Jun;5(3):176-81. doi: 10.1097/01.HDX.0000074436.09658.3b.
3
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
Int J Clin Pharmacol Res. 1984;4(1):19-23.
4
Relationship between plasma propranolol concentration and dose in young, healthy volunteers.年轻健康志愿者血浆中普萘洛尔浓度与剂量之间的关系。
Biopharm Drug Dispos. 1986 Mar-Apr;7(2):103-11. doi: 10.1002/bdd.2510070202.
5
High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.高剂量普萘洛尔治疗心绞痛:剂量与血药浓度及血流动力学结果的关系。
Yale J Biol Med. 1980 May-Jun;53(3):173-9.
6
Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.犬长期给药期间普萘洛尔生物利用度的立体选择性增加。
J Pharmacol Exp Ther. 1983 Nov;227(2):360-4.
7
Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.一项关于新型胆碱酯酶和选择性单胺氧化酶-A抑制剂去氧佩甘宁的随机、交叉、单盲、安慰剂对照人体药理学临床试验:多剂量药代动力学
Int J Clin Pharmacol Ther. 2009 Jul;47(7):483-90.
8
Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.影响普萘洛尔在人体药代动力学的肝脏代谢分析。
Int J Pharm. 2008 Feb 12;349(1-2):53-60. doi: 10.1016/j.ijpharm.2007.07.019. Epub 2007 Jul 24.
9
[Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
J Pharmacol. 1983 Jan-Mar;14(1):47-55.
10
Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.健康比格犬静脉注射和口服别嘌醇后的生物利用度和药代动力学
Am J Vet Res. 1997 May;58(5):504-10.

引用本文的文献

1
Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.普萘洛尔在婴儿血管瘤系统治疗中婴儿的药代动力学:模型建立和给药方案建议。
Pharmacol Res Perspect. 2018 Apr 30;6(3):e00399. doi: 10.1002/prp2.399. eCollection 2018 Jun.
2
Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.健康受试者中两种剂量长效普萘洛尔(80毫克和160毫克)的药代动力学和药效学比较。
Br J Clin Pharmacol. 1989 May;27(5):539-45. doi: 10.1111/j.1365-2125.1989.tb03415.x.
3
Effect of exercise on propranolol pharmacokinetics.
运动对普萘洛尔药代动力学的影响。
Eur J Clin Pharmacol. 1990;39(4):391-4. doi: 10.1007/BF00315416.